Harkema Jack R, Keeler Gerald, Wagner James, Morishita Masako, Timm Edward, Hotchkiss Jon, Marsik Frank, Dvonch Timothy, Kaminski Norbert, Barr Edward
Department of Pathobiology and Diagnostic Investigation, Michigan State University, 212 Food, Safety and Toxicology Building, East Lansing MI 48824, USA.
Res Rep Health Eff Inst. 2004 Aug(120):1-68; discussion 69-79.
Epidemiological studies have reported that elevated levels of particulate air pollution in urban communities are associated with increases in attacks of asthma based on evidence from hospital admissions and emergency department visits. Principal pathologic features of chronic airway diseases, like asthma, are airway inflammation and mucous hypersecretion with excessive amounts of luminal mucus and increased numbers of mucus-secreting cells in regions of the respiratory tract that normally have few or no mucous cells (ie, mucous cell metaplasia). The overall goal of the present project was to understand the adverse effects of urban air fine particulate matter (PM2.5; < or = 2.5 pm in aerodynamic diameter)* on normal airways and airways compromised with airway inflammation and excess mucus. Our project was specifically designed to (1) examine the chemical and physical characteristics of PM2.5 and other airborne pollutants in the outdoor air of a local Detroit community with a high incidence of childhood asthma; (2) determine the effects of this community-based PM2.5 on the airway epithelium in normal rats and rats compromised with preexisting hypersecretory airway diseases (ie, animal models of human allergic airway disease--asthma and chronic bronchitis); and (3) identify the chemical or physical components of PM2.5 that are responsible for PM2.5 -induced airway inflammation and epithelial alterations in these animal models. Two animal models of airway disease were used to examine the effects of PM2.5 exposure on preexisting hypersecretory airways: neutrophilic airway inflammation induced by endotoxin challenge in F344 rats and eosinophilic airway inflammation induced by ovalbumin (OVA) challenge in BN rats. A mobile air monitoring and exposure laboratory equipped with inhalation exposure chambers for animal toxicology studies, air pollution monitors, and particulate collection devices was used in this investigation. The mobile laboratory was parked in a community in southwestern Detroit during the summer months when particulate air pollution is usually high (July and September 2000). We monitored the outdoor air pollution in this community daily, and exposed normal and compromised rats to concentrated PM2.5 from this local urban atmosphere. Rats in the inhalation studies were exposed for 1 day or for 4 or 5 consecutive days (10 hours/day) to either filtered air (controls) or concentrated ambient particles (CAPs) delivered by a Harvard ambient fine particle concentrator. Rats were killed 24 hours after the end of the exposure. Biochemical, morphometric, and molecular techniques were used to identify airway epithelial and inflammatory responses to CAPs. Lung lobes were also either intratracheally lavaged with saline to determine cellular composition and protein in bronchoalveolar lavage fluid (BALF) or removed for analysis by inductively coupled plasma-mass spectrometry (ICPMS) to detect retention of ambient PM2.5--derived trace elements. The Harvard concentrator effectively concentrated the fine ambient particles from this urban atmosphere (10-30 times) without significantly changing the major physicochemical features of the atmospheric particles. Daily CAPs mass concentrations during the 10-hour exposure period (0800-1800) in July ranged from 16 to 895 microg/m3 and in September ranged from 81 to 755 microg/m3. In general, chemical characteristics of ambient particles were conserved through the concentrator into the exposure chamber. Single or repeated exposures to CAPs did not cause adverse effects in the nasal or pulmonary airways of healthy F344 or BN rats. In addition, CAPs-related toxicity was not observed in F344 rats pretreated with bacterial endotoxin. Variable airway responses to CAPs exposure were observed in BN rats with preexisting allergic airway disease induced by OVA sensitization and challenge. Only OVA-challenged BN rats exposed to CAPs for 5 consecutive days in September 2000 had significant increases in airway mucosubstances and pulmonary inflammation compared to saline-challenged/air-exposed control rats. OVA-challenged BN rats that were repeatedly exposed to CAPs in July 2000 had only minor CAPs-related effects. In only the September 5-day exposure protocol, PM2.5 trace elements of anthropogenic origin (La, V, and S) were recovered from the lung tissues of CAPs-exposed rats. Recovery of these specific trace elements was greatest in rats with OVA-induced allergic airway disease. Additional laboratory experiments using intratracheal instillations of ambient PM2.5 samples were performed to identify bioactive agents in the CAPs to which rats had been exposed in the inhalation exposure component. Because the most pronounced effects of CAPs inhalation were found in BN rats with OVA-induced allergic airways exposed in September, we used ambient PM2.5 samples that were collected on 2 days during the September CAPs inhalation exposures to use for instillation. Ambient PM2.5 samples were collected, fractionated into soluble and insoluble species, and then compared with each other and with total PM2.5 for their effects in healthy BN rats and those with OVA-induced allergic airway disease. Intratracheal instillation of the insoluble fraction of PM2.5 caused mild neutrophilic inflammation in the lungs of healthy rats. However, total PM2.5 or the soluble or insoluble fractions instilled in rats with OVA-induced airway inflammation did not enhance the inflammation or the airway epithelial remodeling that was evident in some of the BN rats exposed to CAPs by inhalation. Therefore, the results from this instillation component did not suggest what fractions of the CAPs may have been responsible for enhancing OVA-induced airway mucosubstances and pulmonary inflammation observed in the inhalation exposure component. In summary, inhaled CAPs-related pulmonary alterations in the affected OVA-challenged rats appeared to be related to the chemical composition, rather than the mass concentration, to which the animals were exposed. Results of the trace element analysis in the lungs of CAPs-exposed BN rats exposed in September suggested that air particles derived from identified local combustion sources were preferentially retained in allergic airways. These results demonstrate that short-term exposures to CAPs from this southwestern Detroit community caused variable responses in laboratory rats and suggest that adverse biological responses to ambient PM2.5 may be associated more closely with local sources of particles and weather patterns than with particle mass.
流行病学研究报告称,基于医院收治情况和急诊科就诊情况的证据,城市社区空气中颗粒物污染水平升高与哮喘发作增加有关。慢性气道疾病(如哮喘)的主要病理特征是气道炎症和黏液分泌过多,呼吸道中通常很少或没有黏液细胞的区域(即黏液细胞化生)会出现管腔内黏液过多和黏液分泌细胞数量增加。本项目的总体目标是了解城市空气中细颗粒物(PM2.5;空气动力学直径≤2.5微米)对正常气道以及因气道炎症和黏液过多而受损的气道的不利影响。我们的项目专门设计用于:(1)研究底特律当地一个儿童哮喘高发社区室外空气中PM2.5和其他空气传播污染物的化学和物理特性;(2)确定这种基于社区的PM2.5对正常大鼠和患有先前分泌过多性气道疾病(即人类过敏性气道疾病——哮喘和慢性支气管炎的动物模型)的大鼠气道上皮的影响;(3)确定PM2.5中导致这些动物模型中PM2.5诱导的气道炎症和上皮改变的化学或物理成分。使用两种气道疾病动物模型来研究暴露于PM2.5对先前分泌过多的气道的影响:F344大鼠经内毒素激发诱导的中性粒细胞气道炎症和BN大鼠经卵清蛋白(OVA)激发诱导的嗜酸性粒细胞气道炎症。本研究使用了一个配备有用于动物毒理学研究的吸入暴露室、空气污染监测仪和颗粒物收集装置的移动空气监测与暴露实验室。在颗粒物空气污染通常较高的夏季(2000年7月和9月),移动实验室停在底特律西南部的一个社区。我们每天监测该社区的室外空气污染,并将正常和受损大鼠暴露于来自当地城市大气的浓缩PM2.5中。吸入研究中的大鼠暴露1天或连续4或5天(每天10小时),分别暴露于过滤空气(对照组)或由哈佛环境细颗粒物浓缩器输送的浓缩环境颗粒物(CAPs)。暴露结束后24小时处死大鼠。使用生化、形态计量和分子技术来确定气道上皮对CAPs的反应以及炎症反应。还对肺叶进行气管内盐水灌洗以确定支气管肺泡灌洗液(BALF)中的细胞组成和蛋白质,或取出肺叶通过电感耦合等离子体质谱法(ICPMS)进行分析以检测环境PM2.5衍生微量元素的留存情况。哈佛浓缩器有效地浓缩了来自该城市大气的细环境颗粒物(10 - 30倍),而没有显著改变大气颗粒物的主要物理化学特征。7月10小时暴露期(0800 - 1800)期间的每日CAPs质量浓度范围为16至895微克/立方米,9月范围为81至755微克/立方米。一般来说,环境颗粒物的化学特征通过浓缩器保留到暴露室中。单次或重复暴露于CAPs对健康的F344或BN大鼠的鼻或肺气道没有造成不利影响。此外,在经细菌内毒素预处理的F344大鼠中未观察到与CAPs相关的毒性。在经OVA致敏和激发诱导患有先前过敏性气道疾病的BN大鼠中,观察到对CAPs暴露的气道反应存在差异。与盐水激发/空气暴露的对照大鼠相比,仅2000年9月连续5天暴露于CAPs的经OVA激发的BN大鼠气道黏液物质和肺部炎症有显著增加。2000年7月反复暴露于CAPs的经OVA激发的BN大鼠仅出现与CAPs相关的轻微影响。仅在9月的5天暴露方案中,从暴露于CAPs的大鼠肺组织中回收了人为来源的PM2.5微量元素(镧、钒和硫)。在患有OVA诱导的过敏性气道疾病的大鼠中,这些特定微量元素的回收率最高。使用气管内滴注环境PM2.5样品进行了额外的实验室实验,以确定大鼠在吸入暴露部分中暴露于其中的CAPs中的生物活性剂。由于吸入CAPs的最显著影响在9月暴露的患有OVA诱导的过敏性气道的BN大鼠中发现,我们使用在9月CAPs吸入暴露期间2天收集的环境PM2.5样品进行滴注。收集环境PM2.5样品,分离成可溶和不可溶部分,然后将它们相互比较,并与总PM2.5比较它们对健康BN大鼠和患有OVA诱导的过敏性气道疾病的大鼠的影响。气管内滴注PM2.5的不可溶部分在健康大鼠的肺部引起轻度中性粒细胞炎症。然而,滴注到患有OVA诱导的气道炎症的大鼠中的总PM2.5或可溶或不可溶部分并未增强在一些通过吸入暴露于CAPs的BN大鼠中明显的炎症或气道上皮重塑。因此,该滴注部分的结果并未表明CAPs的哪些部分可能是导致在吸入暴露部分中观察到的增强OVA诱导的气道黏液物质和肺部炎症的原因。总之,在受影响的经OVA激发的大鼠中,吸入与CAPs相关的肺部改变似乎与动物暴露的化学成分有关,而不是与质量浓度有关。9月暴露于CAPs的BN大鼠肺部微量元素分析结果表明,来自已确定的当地燃烧源的空气颗粒优先保留在过敏性气道中。这些结果表明,短期暴露于来自底特律西南部社区的CAPs会在实验大鼠中引起不同的反应,并表明对环境PM2.5的不良生物学反应可能与颗粒的本地来源和天气模式比与颗粒质量更密切相关。